Home For patients

Recent News

Device Trial Rapid Enrollment

Tranquil Clinical Research successfully recruited and enrolled a difficult interventional device trial within two months; where the sponsor's other sites were unable to enroll in 18 months; becoming the highest enrolling clinical research unit and with 100% quality dat
continue reading

Study of COVID treatment Quellor has first patient at Louisville hospital

Tranquil is proud to announce the success of our strategic research site partner, the cardiology research team at Jewish Hospital in Louisville, KY! Dr. Naresh Solankhi & his team successfully treated the the first US patient to participate in a...
continue reading

INmune Bio, Inc. Announces First Patient Dosed in Phase 2 Trial of Quellor™ for Pulmonary Complications in COVID-19 Patients

Congratulations to INmune Bio! Tranquil is proud to be a part of this tremendous effort on enrolling the first patient to this important study. LA JOLLA, Calif, Nov. 09, 2020 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the, “Company”),...
continue reading

Quickest Site Activation

Tranquil Clinical Research was the fastest site activated and quickest site to enroll on a Pivotal COVID clinical trial for a top 20 Pharmaceutical Sponsor.
continue reading

Our Doctors

Dr. Joe Pouzar

Clear Lake Health

Dr. Mohamed Haq

Houston Cancer Institute

Dr. Mark Deandrea

University Cancer Center

Dr. Amir Salam

Salam Oncology Consultants

Dr. Jason Gukhool

Elite and Affinity free standing hospital

Tranquil Clinical Research provides the expertise you need from study start up to closeout and everything in between.